Atlas Trials

Study of Lymphopenia as a Specific Biomarker or Prognostic Risk Factor for Disease Severity in Elderly Patients With COVID-19

Clinical trial NCT04800731 · COMPLETED

Trial details

NCT number
NCT04800731
Sponsor
Universitair Ziekenhuis Brussel
Status
COMPLETED
Study type
OBSERVATIONAL
LymphopeniaCovid19Older People
Start date
2021-06-30
Primary completion
2022-06-30
Enrollment
227

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.